care & love
For many people who have recovered from shingles, the lingering nerve discomfort can be just as challenging as the original rash. While pain is the most commonly discussed symptom, persistent itching — known as post-herpetic itch — affects a significant number of individuals and can be equally disruptive to daily life. The good news is that low-level laser therapy, a non-invasive and drug-free approach, has shown promise in addressing both post-herpetic pain and itch by targeting the underlying nerve dysfunction.
Shingles is caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox. After the visible rash heals, some individuals continue to experience nerve-related symptoms — a condition known as postherpetic neuralgia (PHN). While PHN is most often associated with burning, stabbing, or electric-shock-like pain, it can also manifest as intense, unrelenting itching.
This itch is not a skin-level irritation. It originates from damaged nerve fibers that send faulty signals to the brain. When nerves are injured by the shingles virus, they may fire spontaneously or become hypersensitive, leading the brain to interpret these aberrant signals as itching, tingling, or pain. In many cases, patients experience a combination of both sensations simultaneously.
Key point: Post-herpetic itch and post-herpetic pain share the same root cause — nerve damage. This is why therapies that support nerve repair and calm overactive nerve signaling can be effective for both symptoms.
Low-level laser therapy (LLLT), also called photobiomodulation, uses specific wavelengths of light to penetrate the skin and reach underlying tissues. Unlike high-power surgical lasers, LLLT operates at low intensities that do not generate heat or cause tissue damage. Instead, the light energy is absorbed by cells, triggering a cascade of beneficial biological responses.
When laser light reaches damaged nerve tissue, it stimulates the mitochondria — the energy-producing structures within cells — to produce more ATP (adenosine triphosphate). This boost in cellular energy supports several key processes:
These mechanisms explain why B-CURE Laser therapy can address both pain and itch — because both symptoms stem from the same nerve dysfunction that laser therapy is designed to treat.
Research into low-level laser therapy for postherpetic neuralgia has produced encouraging results. A landmark study by Kemmotsu et al. (1991) published in Laser Therapy found that approximately 89% of postherpetic neuralgia patients experienced a "good" or "very good" immediate response to 830nm laser therapy. In long-term follow-up, 12 patients had no pain at all, and 46 reported only slight discomfort.
More recent reviews have confirmed these findings. A systematic review published in the Clinical Journal of Pain included PHN as a specific subgroup and found consistent evidence of significant pain reduction with laser therapy. Studies have also documented improvements in nerve conduction velocity and functional outcomes among patients receiving regular treatment.
While most clinical research has focused on pain, the mechanisms by which laser therapy works — nerve repair, inflammation reduction, and normalization of nerve signaling — apply equally to itch. When nerve fibers heal and stop firing abnormally, both pain and itch signals diminish. This is why many patients who use laser therapy for post-herpetic pain also report relief from accompanying itching and tingling sensations.
To understand why a single therapy can help with two seemingly different symptoms, it helps to look at how nerves transmit sensations. Pain and itch signals travel along overlapping nerve pathways. Both involve small-diameter nerve fibers (C-fibers) and share similar neurochemical mediators. When these fibers are damaged by shingles, they can produce both types of abnormal sensations.
Laser therapy works at the source — the damaged nerve itself — rather than simply blocking one type of signal. By promoting nerve repair and reducing inflammation, it helps restore normal nerve function. As the nerve heals, the aberrant signals that cause both itching and pain gradually subside.
Think of it this way: If a damaged electrical wire is causing both flickering lights and buzzing sounds, fixing the wire itself solves both problems. Laser therapy takes a similar approach — it addresses the underlying nerve damage rather than just muting individual symptoms.
The B-CURE Laser is a portable, cold laser therapy device designed for home use. It delivers low-level laser energy to targeted areas, making it a practical option for individuals managing chronic post-herpetic symptoms. If you are wondering does B-CURE Laser work for nerve-related conditions, clinical evidence and user experiences suggest that consistent use can lead to meaningful improvements in both pain and itch over time.
For those looking into B-CURE Laser how to use for post-herpetic neuralgia, the general approach involves treating the affected area directly and consistently:
| Symptom | Typical Response to Laser Therapy | Expected Timeline |
|---|---|---|
| Burning pain | Reduction in intensity and frequency | 1–4 weeks |
| Itching | Gradual calming of itch sensation | 1–3 weeks |
| Tingling / pins and needles | Decreased frequency of episodes | 2–6 weeks |
| Skin hypersensitivity | Improved tolerance to touch and clothing | 3–8 weeks |
| Deep aching | Slow but steady improvement | 4–12 weeks |
Laser therapy is not an instant fix — it works gradually by supporting the body's natural healing processes. Most users report a progressive reduction in symptoms over several weeks of consistent use. The experience is generally comfortable, with most people feeling only a mild warmth or no sensation at all during treatment.
Unlike oral medications, which may cause drowsiness, dizziness, or digestive issues, laser therapy is non-invasive and drug-free. It can be used alongside other treatments, including prescribed medications, without interference. This makes it particularly appealing for older adults or individuals who cannot tolerate pharmaceutical side effects.
It is important to maintain realistic expectations. Patients with long-standing post-herpetic neuralgia — lasting more than a year — may have more permanent structural nerve changes. In these cases, laser therapy can still provide meaningful symptom reduction, though complete resolution may be less likely. Starting treatment earlier, ideally during or shortly after the shingles episode, may offer the best chance of preventing chronic symptoms.
Interested in learning more about how laser therapy can help with post-herpetic nerve symptoms?
Visit Mona Care to explore the B-CURE Laser and other smart care solutions.
While laser therapy offers a promising option for managing post-herpetic itch and pain, it works best as part of a comprehensive approach. This includes following your healthcare provider's recommendations for antiviral treatment during acute shingles, considering vaccination (the Shingrix vaccine reduces shingles risk by over 90%), and maintaining good overall health to support nerve recovery.
If you experience shingles near the eye, seek immediate medical attention, as this can threaten vision and requires urgent care. Laser therapy is a supportive treatment and should not ｒｅｐｌａｃｅ emergency medical evaluation when needed.
Conclusion: Laser pain relief can indeed be used for post-herpetic itch as well as pain. Because both symptoms originate from the same underlying nerve damage, therapies that promote nerve healing and reduce inflammation — such as low-level laser therapy — can address both simultaneously. With consistent use, a device like the B-CURE Laser offers a safe, non-invasive, and drug-free option for individuals seeking relief from the lingering nerve symptoms that can follow a shingles outbreak.